Skip to content

The effect of plasma rich in growth factors in treatment of gingival recession

Clinical evaluation of the efficacy of plasma rich in growth factors with connective tissue graft in treatment of gingival recession

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201201168747N1
Enrollment
22
Registered
2012-08-26
Start date
2012-05-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gingival Recession. Gingival recession (generalized)(localized)(post infective)(post-operative)

Interventions

Intervention 1: Control group: connective tissue graft with coronally flap advancement. Intervention 2: Intervention group: Moistened connective tissue graft with plasma rich in growth factors and cor
Treatment - Drugs
Control group: connective tissue graft with coronally flap advancement
Intervention group: Moistened connective tissue graft with plasma rich in growth factors and coronally advanced flap

Sponsors

Vice chancellor for research, Babol University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria : 1) The presence of either bilateral isolated or multiple facial defects with recession depths =2 mm when measured from the cementoenamel junction at anterior teeth or premolars; 2) The defects that are judged as Miller Class I or Class II; 3) The selected teeth should be vital, free of restorations or had restorations removed, and with no bleeding upon probing; 4)The age of patients should be within 18 to 65 5) Good oral hygiene (O´Leary plaque score =%20 ); 6)Width of keratinized gingiva should be 0.5mm. Exclusion criteria: 1) Smoking; 2) Any uncontrolled local or systemic disease that might contraindicate periodontal surgery; 3) Pregnancy; 4) Hematologic disorders; 5) Usage of the drugs that have intervention with wound healing (corticosteroid, chemotherapeutic agents); 6) Usage of the drugs that have intervention with platelet aggregation; 7) Allergy to tetracycline; 8) Traumatic methods of tooth brushing; 9) Applying abrasive dentifrices; 10) Applying removable partial denture; 11) The history of periodontal surgery at the selected site.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Gingival recession. Timepoint: Six month after surgery. Method of measurement: Clinical examination.

Secondary

MeasureTime frame
Width of keratinized gingiva. Timepoint: Baseline, 1 and 6 month after surgery. Method of measurement: Clinical examination.;Clinical attachment level. Timepoint: Baseline, 1 and 6 month after surgery. Method of measurement: Clinical examination.;Clinical probing depth. Timepoint: Baseline, 1 and 6 month after surgery. Method of measurement: Clinical examination.;Vertical depth of gingival recession. Timepoint: Baseline, 1 and 6 month after surgery. Method of measurement: Clinical examination.;Width of gingival recession. Timepoint: Baseline, 1 and 6 month after surgery. Method of measurement: Clinical examination.;Gingival thickness. Timepoint: Baseline, 1 and 6 month after surgery. Method of measurement: Clinical examination.;Gingival index. Timepoint: Baseline, 1 and 6 month after surgery. Method of measurement: Clinical examination.;The distance between mucogingival junction and cementoenamel junction (Mgjl). Timepoint: Baseline, 1 and 6 month after surgery. Method of measurement: Clinical examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactEhsan Zahedi

Babol Dental School

dr.ehsanzahedi@mubabol.ac.ir+98 11 1229 1093

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026